"10.1371_journal.pone.0135406","plos one","2015-09-01T00:00:00Z","Morten A Nielsen; Mafalda Resende; Willem A de Jongh; Sisse B Ditlev; Benjamin Mordmüller; Sophie Houard; Nicaise Tuikue Ndam; Mette Ø Agerbæk; Mette Hamborg; Achille Massougbodji; Saddou Issifou; Anette Strøbæk; Lars Poulsen; Odile Leroy; Peter G Kremsner; Jean-Philippe Chippaux; Adrian J F Luty; Philippe Deloron; Thor G Theander; Charlotte Dyring; Ali Salanti","Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Science, University of Copenhagen, and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark; ExpreS2ion Biotechnologies, SCION-DTU Science Park, Hørsholm, Denmark; Eberhard Karls Universität Tübingen, Institut für Tropenmedizin, Tübingen, Germany, and Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; European Vaccine Initiative, Universitäts Klinikum Heidelberg, Heidelberg, Germany; Institut de Recherche pour le Développement, UMR216 Mère et enfant face aux infections tropicales, Paris, France; PRES Sorbonne Paris Cité, Université Paris Descartes, Paris, France; Faculté des Sciences de la Santé de lUniversité dAbomey-Calavi, Centre détude et de recherche sur le paludisme associé à la grossesse et à lenfance, Cotonou, Bénin","Conceived and designed the experiments: MAN MR PD TGT WAdJ CD A. Salanti. Performed the experiments: MAN MR WAdJ SBD MØA MH CD A. Strøbæk LP. Analyzed the data: MAN WAdJ NTN PD TGT CD A. Salanti. Contributed reagents/materials/analysis tools: MAN WAdJ MØA A. Salanti. Wrote the paper: MAN BM SH MØA AJFL PD TGT A. Salanti. Designed the clinical trial described: MAN BM SH NTN AM SI OL PGK JPC AJFL PD TGT.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: Willem A. de Jongh, Anette Strøbæk, Lars Poulsen & Charlotte Dyring are affiliated with the private company Expres2ion Biotechnologies. There are no products in development or marketed products to declare. AS and TGT are owners of European patent WO2004067559 (Compounds useful in the diagnosis and treatment of pregnancy-associated malaria). WAdJ & CD are owners of patents WO 2013174889 A1 (Novel drosophila s2 cell line) & WO 2009150222 A3 (Improved protein expression system). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","09","Morten A Nielsen","MAN",21,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
